Showing 12 out of 2273 items
- Potent combination anti-HIV therapy (ART) became available in 1996 in Canada and other high-income countries. The arrival of ART marked an important turning ...
- As mentioned earlier in this issue of TreatmentUpdate, researchers are testing simplified regimens for maintenance treatment for HIV. Results from pilot studies ...
- A pill containing two anti-HIV drugs - dolutegravir + rilpivirine - has been approved for use in Canada, the European Union and the United States. This pill is ...
- The drug dolutegravir is a widely used part of combination therapy for HIV treatment. Dolutegravir belongs to a class of drugs called integrase inhibitors; it ...
- As explained earlier in this issue of TreatmentUpdate, clinical trials with dual drug regimens based on the powerful integrase inhibitor dolutegravir are ...
- Although effective HIV treatment (ART) exists, researchers are studying other potential treatments such as a group of antibodies that are highly efficient at ...
- The immune system has many different mechanisms for detecting bacteria, fungi and viruses. One such mechanism uses a series of proteins called toll-like ...
- CATIE NewsA 2018 survey asked Canadians about sexually transmitted and blood-borne infections. The survey included questions about knowledge, awareness and attitudes. ...
- Indigenous peoples in Canada experience social and health disparities due to the ongoing effects of racism, colonization, and intergenerational trauma from forced family separation by the residential…
- Symtuza contains four medicines - darunavir, cobicistat, tenofovir alafenamide (TAF) and FTC.
- Isentress HD contains the anti-HIV drug raltegravir. Isentress HD belongs to the class of drugs called integrase inhibitors.
- 2018 has been a pivotal year for HIV and hepatitis C prevention, testing and treatment. Researchers and clinicians have pioneered game-changing HIV ...